Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05301816 · ClinicalTrials.gov registry record · NA
PDN Post Market, Multicenter, Prospective, Global Clinical Study
A NA study of Diabetic Neuropathy, Painful, sponsored by Nevro.
- Recruiting
- Registry status
- NA
- Development phase
- 497
- Enrollment target
- 8
- Study locations
NCT05301816 is a NA study of Diabetic Neuropathy, Painful that is actively recruiting participants, run by Nevro. The registered enrollment target is 497 participants. The trial reports 8 study locations across 7 states.
The verdict
NCT05301816, a NA study of Diabetic Neuropathy, Painful, is actively recruiting participants, sponsored by Nevro.
- RECRUITING
- Registry status
- NA
- Development phase
- 497 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this post-market study is to evaluate the real-world experience of Nevro's Spinal Cord Stimulation (SCS) therapy in patients with chronic, intractable leg pain due to painful diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study, that will partner diabetes management teams with pain physicians to provide an interdisciplinary treatment regimen for PDN patients. Outcomes will be assessed via standardized assessments.
Conditions Studied
Interventions
- DEVICE Spinal Cord Stimulator (SCS)
Study Locations (8)
Michigan
- Michigan Pain Specialists - Ann Arbor
- Henry Ford Health - West Bloomfield
Alaska
- Neuroversion, Inc. - Anchorage
Ohio
- Ohio State University Wexner Medical Center - Columbus
Oklahoma
- Clinical Investigations, LLC - Edmond
Oregon
- Columbia Pain Management - Milwaukie
Pennsylvania
- WellSpan Interventional Pain Specialists - York
Virginia
- Virginia Interventional Pain & Spine Centers - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 497 participants |
| Start Date | 2022-07-05 |
| Est. Completion | 2028-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05301816
The ClinicalTrials.gov registry entry for NCT05301816 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 497 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nevro, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Neuropathy, Painful appearing as the primary indexed condition, and to 1 intervention - of which Spinal Cord Stimulator (SCS) is the first listed.
NCT05301816 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Michigan, Alaska, Ohio.
Frequently Asked Questions
What is clinical trial NCT05301816 about?
NCT05301816 is a clinical study titled "PDN Post Market, Multicenter, Prospective, Global Clinical Study". The purpose of this post-market study is to evaluate the real-world experience of Nevro's Spinal Cord Stimulation (SCS) therapy in patients with chronic, intractable leg pain due to painful diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study, that will partner d...
What is the current status of trial NCT05301816?
This trial is currently recruiting. It is a NA study. The enrollment target is 497 participants. The study started on 2022-07-05. Estimated completion is 2028-10.
What conditions does trial NCT05301816 study?
This clinical trial studies the following conditions: Diabetic Neuropathy, Painful.
What interventions are being tested in trial NCT05301816?
The interventions under investigation include: Spinal Cord Stimulator (SCS) (DEVICE).
Who is sponsoring clinical trial NCT05301816?
This trial is sponsored by Nevro, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05301816 being conducted?
This trial has 8 study locations across Alaska, Michigan, Ohio, Oklahoma, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Neuropathy, Painful
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.